Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00275769 · ClinicalTrials.gov registry record · NA

CAPTURE - Complete Automatic Pacing Threshold Utilization Recorded by EnPulse

A NA study of Bradycardia and Arrhythmia, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

Completed
Registry status
NA
Development phase
860
Enrollment target
20
Study locations

NCT00275769 is a NA study of Bradycardia and Arrhythmia that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 860 participants, below the 4,383-participant average among 29 other Bradycardia trials with a reported enrollment target (80% lower). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00275769, a NA study of Bradycardia and Arrhythmia, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

COMPLETED
Registry status
NA
Development phase
860 participants
Enrollment target
20
Study locations

Study Summary

This study compares the pacemaker's automatic pacing threshold measurements to the manual measurements conducted by a health care provider.

Conditions Studied

Interventions

  • DEVICE Pacemaker

Study Locations (20)

California

  • - Fullerton
  • - Oceanside
  • - Redondo Beach
  • - Stanford

Florida

  • - Brandon
  • - Daytona Beach
  • - Orlando
  • - Sarasota

Alabama

  • - Anchorage
  • - Mobile

Georgia

  • - Athens
  • - Gainsville

Illinois

  • - Chicago
  • - Peoria

Colorado

  • - Colorado Springs

District of Columbia

  • - Washington D.C.

Iowa

  • - Des Moines

Trial Details

FieldValue
Enrollment Target 860 participants
Start Date 2004-03
Est. Completion 2006-09
Phase NA

What the Registry Record Tells You About NCT00275769

The ClinicalTrials.gov registry entry for NCT00275769 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 860 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,383-participant average among 29 other Bradycardia trials with a reported enrollment target (80% lower). The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Bradycardia appearing as the primary indexed condition, and to 1 intervention - of which Pacemaker is the first listed.

NCT00275769 reports 20 study locations spanning 11 distinct geographic areas - top geographies include California, Florida, Alabama.

Frequently Asked Questions

What is clinical trial NCT00275769 about?

NCT00275769 is a clinical study titled "CAPTURE - Complete Automatic Pacing Threshold Utilization Recorded by EnPulse". This study compares the pacemaker's automatic pacing threshold measurements to the manual measurements conducted by a health care provider.

What is the current status of trial NCT00275769?

This trial is currently completed. It is a NA study. The enrollment target is 860 participants. The study started on 2004-03. Estimated completion is 2006-09.

What conditions does trial NCT00275769 study?

This clinical trial studies the following conditions: Bradycardia, Arrhythmia.

What interventions are being tested in trial NCT00275769?

The interventions under investigation include: Pacemaker (DEVICE).

Who is sponsoring clinical trial NCT00275769?

This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00275769 being conducted?

This trial has 20 study locations across Alabama, California, Colorado, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bradycardia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.